Hyperthermia therapy market seen reaching $0.38 billion by 2030

The hyperthermia therapy market is projected to grow from $0.25 billion in 2025 to $0.38 billion by 2030, according to The Business Research Company. Rising cancer cases, wider use of minimally invasive treatments and new temperature-monitoring technologies are driving the outlook.

Why it matters: - Hyperthermia therapy is gaining traction as a cancer treatment that can support chemotherapy and radiotherapy. - The market’s projected growth signals more demand for complementary, minimally invasive oncology tools. - The World Health Organization said new cancer cases reached 20.6 million in 2024 and could approach 35 million by 2050, underscoring the scale of the treatment need.

What happened: - The Business Research Company released its Hyperthermia Therapy Global Market Report 2026 covering market size, trends and forecasts through 2035. - The report projects the market will rise from $0.25 billion in 2025 to $0.27 billion in 2026. - The report also projects the market will reach $0.38 billion by 2030. - The report puts 2025-2026 growth at an 8.5% CAGR. - The report forecasts an 8.7% CAGR through 2030. - The release was issued from London on Sept. 21, 2026. - A free sample of the report is available here. - The full report is available here.

The details: - Hyperthermia therapy uses controlled heat on targeted tissue to create therapeutic effects. - The treatment is designed to improve cellular function, increase blood circulation and help other therapies work better. - Specialized devices deliver regulated heat while protecting nearby healthy tissue. - Growth drivers in the report include rising cancer cases, broader acceptance of hyperthermia as a complementary treatment, preference for minimally invasive therapies, stronger oncology infrastructure and more clinical research on thermal therapy. - The report says future growth will be supported by precision medicine, demand for individualized cancer treatment, advanced thermometry, combination therapies and funding for next-generation devices. - Emerging trends include new heat-delivery methods, personalized treatment protocols, real-time temperature monitoring and wider use of non-invasive thermal therapies with radiation and chemotherapy. - In 2025, North America held the largest market share. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - Other regions covered include South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast suggests hyperthermia therapy is moving from a niche option toward a more established part of cancer care. - The strongest demand appears tied to combination treatment approaches rather than standalone use. - Regional momentum is split: mature healthcare systems are leading adoption now, while investment and awareness are likely to accelerate growth in emerging markets. - The report’s emphasis on real-time monitoring and precision tools points to a market that is becoming more technology-driven.

What's next: - The Business Research Company expects the market to keep expanding through 2030 as cancer incidence rises and treatment technologies improve. - Next-generation devices and more personalized protocols are likely to shape product development and competitive positioning. - Broader adoption will depend on continued clinical research, healthcare investment and access to advanced oncology infrastructure.

The bottom line: - Hyperthermia therapy is set for steady growth, powered by rising cancer demand and better technology, with the market forecast to nearly double from 2025 to 2030.